Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001361423 | SCV001557399 | uncertain significance | Gastrointestinal stromal tumor | 2020-01-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with KIT-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 387 of the KIT protein (p.Gly387Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. |
Ambry Genetics | RCV003298570 | SCV004009414 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-04-30 | criteria provided, single submitter | clinical testing | The p.G387R variant (also known as c.1159G>A), located in coding exon 7 of the KIT gene, results from a G to A substitution at nucleotide position 1159. The glycine at codon 387 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |